Advertisement

Cosmetic Approach During Pregnancy

  • Luna Azulay-AbulafiaEmail author
  • Eduardo de Oliveira Vieira
Living reference work entry

Latest version View entry history

Part of the Clinical Approaches and Procedures in Cosmetic Dermatology book series (CAPCD)

Abstract

Pregnancy is a very special moment for every woman, and some physiologic changes occur in her body, including the skin. Skin treatment can be necessary to control some disease that can begin or get worse during pregnancy, and dermatologists must know what can or cannot be prescribed during this period. Clinical and side effects of many different medicaments are well studied and when correctly indicated they can be used. On the other hand, few data about the benefits and the harmfulness of cosmetics and cosmeceuticals is available. This chapter will approach what is known about cosmetics and cosmeceuticals, the indication and the contraindication of these products during pregnancy.

Keywords

Pregnancy Cosmetic Cosmeceutical Skin Nail Hair Fetus Embryo 

References

  1. Akhavan A, Bershad S. Topical acne drugs: review of clinical properties, systemic exposure, and safety. Am J Clin Dermatol. 2003;4:473–92.CrossRefPubMedGoogle Scholar
  2. Andersen F. Amended final report on the safety assessment of ethyl methacrylate. Int J Toxicol. 2002;21(Suppl):63–79.Google Scholar
  3. Andersen A. Amended final report of the safety assessment of dibutyl adipate as used in cosmetics. Int J Toxicol. 2006;25 Suppl 1:129–34.PubMedGoogle Scholar
  4. Bozzo P, Chua-Gocheco A, Einarson A. Safety of skin care products during pregnancy. Can Fam Phys Le Méd Famille Can. 2011;57:665–7.Google Scholar
  5. Brennan M, Young G, Devane D. Topical preparations for preventing stretch marks in pregnancy. Cochrane Database Syst Rev. 2012; 11:CD000066. doi:10.1002/14651858.CD000066.pub2.Google Scholar
  6. Burnett CL, Bergfeld WF MD, FACP, Belsito DV MD, Hill RA PhD, Klaassen CD PhD, Liebler DC PhD, Marks Jr JG MD, Shank RC PhD, Slaga TJ PhD, Snyder PW DVM, PhD, Andersen FA PhD, Burnett CL, Bergfeld WF, Belsito DV, et al. Final report of the safety assessment of kojic acid as used in cosmetics. Int J Toxicol. 2010;29:244S–73.CrossRefPubMedGoogle Scholar
  7. Camera G, Pregliasco P. Ear malformation in baby born to mother using tretinoin cream. Lancet. 1992;339:687.CrossRefPubMedGoogle Scholar
  8. Choi CM, Berson DS. Cosmeceuticals. Semin Cutan Med Surg. 2006;25(3):163–8.CrossRefPubMedGoogle Scholar
  9. Cilliers J. Use of kojic acid to treat superficial cutaneous hyperpigmentation. Disponível em: http://www.magiclear.co.za/MagiClearKojicAcid.html
  10. Couto AC, Ferreira JD, Rosa ACS, Pombo-de-Oliveira MS, Koifman S, Brazilian Collaborative Study Group of Infant Acute Leukemia. Pregnancy, maternal exposure to hair dyes and hair straightening cosmetics, and early age leukemia. Chem Biol Interact. 2013;205:46–52.CrossRefPubMedGoogle Scholar
  11. del Rosso JQ. Moisturizers: function, formulation and clinical applications. capitulo 14 pags 97 a 102) in Cosmeceuticals Draelos. 2009:97–102.Google Scholar
  12. Dickenson CA MA, Woodruff TJ, Stotland NE, Dobraca D, Das R. Elevated mercury levels in pregnant woman linked to skin cream from Mexico. Am J Obstet Gynecol Case Rep. 2013;209:e4–5.CrossRefGoogle Scholar
  13. Duarte I, Buense R, Lazzarini R. Cosméticos na Gravidez. In: Tedesco JJA, editor. A Grávida: suas indagações e as dúvidas do Obstetra. São Paulo: Editora Atheneu; 1999. p. 141–65.Google Scholar
  14. Elder RL. Final report on the safety assessment of ethyl acetate and butyl acetate. J Am Coll Toxicol. 1989;8:681–705.CrossRefGoogle Scholar
  15. Ema M, Miyawaki E, Kawashima K. Further evaluation of developmental toxicity of di n-butyl phthalate following administration during late pregnancy in rats. Toxicol Lett. 1998;98:87–93.CrossRefPubMedGoogle Scholar
  16. Grunewald S, Jank A. New systemic agents in dermatology with respect to fertility, pregnancy, and lactation. J Ger Soc Dermatol. 2015;1304:277–90.Google Scholar
  17. Jick SS, Terris BZ, Jick H. First trimester topical tretinoin and congenital disorders. Lancet. 1993;341:1181–2.CrossRefPubMedGoogle Scholar
  18. Johnson Jr W. Safety assessment of MIBK (Methyl Isobutyl Ketone). Int J Toxicol. 2004;23(Suppl):29–57.PubMedGoogle Scholar
  19. Kligman AM. O que são cosmecêuticos. In: Draelos ZD, Dover JS, editors. Cosmecêuticos. Rio de Janeiro: Elsevier; 2005a. p. 1–2.Google Scholar
  20. Kligman A. The future of cosmeceuticals: an interview with Albert Kligman, MD, PhD. Dermatol Surg. 2005b;31(7 part 2):890–1.PubMedGoogle Scholar
  21. Kroumpouzos G, Draelos Z. Skin care products, cosmetics and cosmeceuticals. In: Kroumpouzos G, editor. Text atlas of obstetric dermatology. Philadelphia: Lippincott Williams & Wilkins Publishers; 2013. p. 251–7.Google Scholar
  22. Leachman AS, Reed BR. The use of dermatologic drugs in pregnancy and lactation. Dermatol Clin. 2006;24:167–97.CrossRefPubMedGoogle Scholar
  23. Levy S. Estimated exposure to phthalates in cosmetics and risk assessment. J Toxicol Environ Health. 2004;67:23–4.CrossRefGoogle Scholar
  24. Lipson AH, Collins F, Webster WS. Multiple congenital defects associated with maternal use of topical tretinoin. Lancet. 1993;341:1352–3.CrossRefPubMedGoogle Scholar
  25. Loureiro KD, Kao KK, Jones KL, Alvarado S, Chavez C, Dick L, Felix R, Johnson D, Chambers CD. Minor malformations characteristic of the retinoic acid embryopathy and other birth outcomes in children of women exposed to topical tretinoin during early pregnancy birth outcomes and topical tretinoin. Am J Med Genet. 2005;136A:117–21.CrossRefGoogle Scholar
  26. Mahé A, Perret JL, Ly F, Fall F, Rault JP, Dumont A. The cosmetic use of skin-lightening products during pregnancy in Dakar, Senegal: a common and potentially hazardous practice. Trans R Soc Trop Med Hyg. 2007;101:183–7.CrossRefPubMedGoogle Scholar
  27. Nakagawa M, Kawai K, Kawai K. Contact allergy to kojic acid in skin care products. Contact Dermatitis. 1995;32(1):9–13.CrossRefPubMedGoogle Scholar
  28. Navarre-Belhassen C, Blanchet P, Hillaire-Buys D, et al. Multiple congenital malformations associated with topical tretinoin. Ann Pharmacother. 1998;32:505–6.CrossRefPubMedGoogle Scholar
  29. Odio MR, et al. Evaluation of subchronic (13 week), reproductive, and in vitro genetic toxicity potential of 2-ethylhexyl-2-cyano-3,3-diphenyl acrylate (octocrylene). Fundam Appl Toxicol. 1994;22(3):355–68.CrossRefPubMedGoogle Scholar
  30. Panchaud AP, Csajka C, Merlob P, Sshaefer C, Berlin M, De Santis M, Vial T, Ieri A, Malm H, Eleftheriou G, Stahl B, Rousso P, Winterfield U, Rothuizen LE, Buclin T. Pregnancy outcome following exposure to topical retinoids: a multicenter prospective study. J Clin Pharmacol. 2012;52:1844–51.CrossRefPubMedGoogle Scholar
  31. Purim KSM, Avelar MFS. Fotoproteção, melasma e qualidade de vida em gestantes. Photoprotection, melasma and quality of life in pregnant women. Rev Bras Ginecol Obstet. 2012;34(5):228–34.CrossRefPubMedGoogle Scholar
  32. Shapiro L, Pastuszak A, Curto G, Koren G. Safety of first-trimester exposure to topical tretinoin: prospective cohort study. Lancet. 1997;350:1143–4.CrossRefPubMedGoogle Scholar
  33. Simion FA, Abrutyn ES, Draelos ZD. Ability of moisturizers to reduce dry skin and irritations and to prevent their return. J Cosmet Sci. 2005;56(6):427–44.PubMedGoogle Scholar
  34. Tyl RW, Price CJ, Marr MC, et al. Developmental toxicity evaluation of sodium thioglycolate administered topically to Sprague-Dawley (CD) rats and New Zealand white rabbits. Birth Defects Res B Dev Reprod Toxicol. 2003;68(2):144–61.CrossRefPubMedGoogle Scholar
  35. Wehr RF, Krochmal L. Considerations in selecting a moisturizer. Cutis. 1987;39:512–5.PubMedGoogle Scholar
  36. Wster RC, Melendres J, Hui X, Cox R, Serranzana S, Zhai H, Quan D, Maibach HI. Human in vivo and in vitro, hydroquinone topical biovailability, metabolism, and disposition. J Toxicol Environ Health A. 1998;54(4):301–17.Google Scholar

Copyright information

© Springer International Publishing AG 2017

Authors and Affiliations

  • Luna Azulay-Abulafia
    • 1
    Email author
  • Eduardo de Oliveira Vieira
    • 1
  1. 1.Universidade Estadual do Rio de JaneiroRio de JaneiroBrazil

Personalised recommendations